As of the year of 2023, the Cancer Plus was transferred to AccScience Publishing (https://www.accscience.com/journal/CP). Articles starting from Volume 5 Issue 1 (2023) will be published by AccScience Publishing, while articles from Volume 1 Issue 1 (2019) to Volume 4 Issue 3 (2022) that were previously published by Whioce Publishing will be hosted by AccScience Publishing as a courtesy and upon the agreement with Whioce Publishing, with the original distribution license being applied. Articles that have been planned to be released as Online First articles will be released and published as such by AccScience Publishing. Please contact the Editor-in-Chief for information regarding the new publisher and any submissions in progress.
Potential of Nutraceutical in Preventing the Risk of Cancer and Metabolic Syndrome: From the Perspective of Nutritional Genomics
Transferrin Receptor Serves as a Potential Target for Cancer Therapy
Research Progress on Anti-angiogenesis Drugs in Hepatocellular Carcinoma
Research progress in bladder cancer
Cancer and Its Relationship with Dietary Patterns in Cordoba, Argentina
Transferrin receptor cluster of differentiation 71: A potential novel target for bladder cancer
Transoral Robotic Surgery for Oropharyngeal Cancer